Clinical Trials in Minneapolis

Showing 6301-6320 of 14,456 trials

Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia

NCT02700048

This is a single center, single-blind randomized cross over design trial that will compare the impact of intra-nasal naloxone vs. intra-nasal saline administration during experimental hypoglycemia on day one on responses to experimental hypoglycemia on day two. Investigators intend to enroll 18 individuals to obtain the complete data sets from 15 participants. Expected duration of subject participation is 10-12 weeks. This study will consist of two 2-day intervention visits separated by approximately 8 weeks.

Hypoglycemia UnawarenessType 1 Diabetes

University of Minnesota11 participantsStarted Jun 2016

Minneapolis, Minnesota, United States

COMPLETEDPhase 3< 1 mile

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

NCT04732949

The purpose of this Phase III study is to confirm that SNG001 can accelerate the recovery of hospitalised patients receiving oxygen with confirmed Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). Safety and other efficacy endpoints will also be assessed.

Severe Acute Respiratory Syndrome Coronavirus 2COVID-19

Synairgen Research Ltd.623 participantsStarted Jan 2021

Tucson, Arizona, United States • St. Petersburg, Florida, United States • Detroit, Michigan, United States +109 more locations

Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

Find Trials by Condition in Minneapolis

N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers

Feasibility Study for Treating Trichotillomania With Wearable Device and App System

Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

OPTIMIZE IDE for the Treatment of ACS

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer

Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Personalized Medicine for Canadians With Hemophilia

A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

3D Prediction of Patient-Specific Response

The TREFOIL Concept 5 Year Clinical Investigation